The Oncology Institute, Inc. (TOI) earnings
TOI earnings moved a median of -0.36% by the close. Quarterly and annual TOI reports and results, each read against the price at its own news timestamp. Back to the TOI overview →
31 measured TOI earnings events.
Where these TOI earnings landedvs 31 measured TOI earnings reactions
| Middle 50% of TOI earnings reactions | -9.36% to +4.42% |
|---|---|
| Median reaction (to close) | -0.36% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 TOI earnings events with a measured close landed between -9.36% and +4.42%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call | Press release | +4.37% | +3.18% | |
| Form 10-Q Oncology Institute, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.99% | -1.24% | |
| The Oncology Institute Reports First Quarter 2026 Financial Results | Press release | +0.99% | -1.24% | |
| The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call | Press release | +0.15% | +2.46% | |
| Form 10-K Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.94% | -10.69% | |
| The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call | Press release | -2.10% | +4.56% | |
| The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call | Press release | +1.59% | +4.77% | |
| Form 10-Q Oncology Institute, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.61% | -8.02% | |
| The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | Press release | +1.61% | -8.02% | |
| The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call | Press release | +1.10% | +1.38% | |
| Form 10-Q Oncology Institute, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.83% | +7.42% | |
| The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | Press release | +2.83% | +7.42% | |
| The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call | Press release | -0.39% | +0.35% | |
| Form 10-K Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.55% | -5.47% | |
| The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call | Press release | -5.49% | -7.97% | |
| Form 10-Q Oncology Institute, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.58% | -10.84% | |
| The Oncology Institute Reports Third Quarter 2024 Financial Results | Press release | -2.58% | -10.84% | |
| The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call | Press release | -0.07% | +0.00% | |
| Form 10-Q Oncology Institute, Inc. For: Jun 30 | SEC filing · Form 10-Q | -7.25% | -13.04% | |
| The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance | Press release | -7.25% | -13.04% | |
| The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call | Press release | +7.65% | +6.26% | |
| Form 10-K/A Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.88% | -0.36% | |
| Form 10-Q/A Oncology Institute, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.88% | -0.36% | |
| Form 10-Q Oncology Institute, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.62% | -22.78% | |
| The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance | Press release | -0.62% | -22.78% | |
| The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call | Press release | +0.00% | +4.42% | |
| Form 10-K/A Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +4.42% | |
| Form 10-K Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.06% | -11.24% | |
| The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call | Press release | +0.00% | -4.12% | |
| Form 10-Q Oncology Institute, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.28% | +21.13% | |
| The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance | Press release | -3.28% | +21.13% |
Keep exploring
More TOI: analyst actions → · SEC filings → · TOI overview →